Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | NAAA | Q02083 | 2/20 | 0.33 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.32 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2743733 | 1.00 | POLB (0.33) | POLBGAAMAPK1NPSR1NAAA | |
| SCHEMBL14045691 | 1.00 | POLB (0.33) | POLBGAAMAPK1NPSR1NAAA | |
| SCHEMBL15083047 | 0.90 | ABCB1 (0.31) | NAAAABCB1 | |
| SCHEMBL8499543 | 0.77 | MAPK1 (0.40) | POLBGAAMAPK1NPSR1ALDH1A1 | |
| SCHEMBL13238258 | 0.76 | POLB (0.33) | POLBGAAMAPK1NPSR1 | |
| SCHEMBL12844988 | 0.75 | POLB (0.31) | POLBGAAMAPK1NPSR1 | |
| SCHEMBL12858607 | 0.75 | POLB (0.31) | POLBGAAMAPK1NPSR1 | |
| SCHEMBL9225694 | 0.74 | POLB (0.30) | POLBGAAMAPK1NPSR1 | |
| SCHEMBL9007453 | 0.71 | KDM6B (0.33) | GAAALDH1A1 | |
| SCHEMBL7149367 | 0.70 | POLB (0.33) | POLBGAAMAPK1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1817319-B1 | INOSITOL-PHOSPHATE DERIVATIVES AND METHOD OF DETECTING INOSITOL-1-PHOSPHATE | CIS BIO INT (FR) | 2013-07-03 | — | — | EP | disclosed |
| US-8178704-B2 | For analyzing seven transmembrane domain receptors coupled to phospholipase C and receptors having tyrosine kinase activity; kits; monoclonal/polyclonal antibodies | CIS BIO INTERNATIONAL (FR) | 2012-05-15 | — | — | US | disclosed |
| US-20080261237-A1 | Inositol-Phosphate Derivatives and Method of Detecting Inositol-1-Phosphate | CIS BIO INTERNATIONAL (FR) | 2008-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080261237-A1 | Inositol-Phosphate Derivatives and Method of Detecting Inositol-1-Phosphate | IPMK, PLCG1, IP6K1 | POLB 2915/4885GAA 3198/4885MAPK1 1109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.